Clinical trial
Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France
NCT01238809 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- June 30, 2011
- Completion date
- July 31, 2011
- Enrollment
- 7,300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
self-administered questionnaire to patients